263 related articles for article (PubMed ID: 31755224)
21. Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Cheng Z; Zhou L; Hu K; Dai Y; Pang Y; Zhao H; Wu S; Qin T; Han Y; Hu N; Chen L; Wang C; Zhang Y; Wu D; Ke X; Shi J; Fu L
Bone Marrow Transplant; 2018 Sep; 53(9):1089-1095. PubMed ID: 29515250
[TBL] [Abstract][Full Text] [Related]
22. High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Zhang J; Zhang L; Cui H; Zhang X; Zhang G; Yang X; Yang S; Zhang Z; Wang J; Hu K; Shi J; Ke X; Fu L
Cancer Gene Ther; 2019 May; 26(5-6):119-127. PubMed ID: 30177817
[TBL] [Abstract][Full Text] [Related]
23. Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.
Ringdén O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M;
Br J Haematol; 2017 Feb; 176(3):431-439. PubMed ID: 27879990
[TBL] [Abstract][Full Text] [Related]
24. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
25. Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients.
Hilberink J; Hazenberg C; van den Berg E; Mulder A; Schuringa JJ; van der Helm L; de Groot M; Choi G; de Bock GH; Vellenga E; Ammatuna E; Huls G
Leuk Res; 2019 May; 80():33-39. PubMed ID: 30954622
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of
Cui W; Liu Y; Tan Y; Peng X; Cui L; Cheng Z; Dai Y; Fu L; Zeng T; Liu Y
Future Oncol; 2021 Feb; 17(5):541-548. PubMed ID: 33467898
[No Abstract] [Full Text] [Related]
27. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.
Imamura T; Iwamoto S; Kanai R; Shimada A; Terui K; Osugi Y; Kobayashi R; Tawa A; Kosaka Y; Kato K; Hori H; Horibe K; Oda M; Adachi S;
Br J Haematol; 2012 Oct; 159(2):204-10. PubMed ID: 22924344
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia.
Li F; Miao J; Liu R; Zhang R; He A
J Cancer Res Clin Oncol; 2024 Mar; 150(3):144. PubMed ID: 38507057
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.
Cui L; Cheng Z; Liu Y; Dai Y; Pang Y; Jiao Y; Ke X; Cui W; Zhang Q; Shi J; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):15-21. PubMed ID: 30578412
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of DOK family adapters in acute myeloid leukemia.
Zhang L; Li R; Hu K; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Shi J; Cheng Z; Fu L
Cancer Gene Ther; 2019 Sep; 26(9-10):305-312. PubMed ID: 30348947
[TBL] [Abstract][Full Text] [Related]
31. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
32. High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Liu Y; Cao Y; Yang X; Chen H; Yang H; Liu Y; Gu W
Transl Cancer Res; 2023 Apr; 12(4):913-927. PubMed ID: 37180663
[TBL] [Abstract][Full Text] [Related]
33. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S
Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286
[TBL] [Abstract][Full Text] [Related]
35. Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia.
Heini AD; Hugo R; Berger MD; Novak U; Bacher U; Pabst T
Hematol Oncol; 2020 Feb; 38(1):74-81. PubMed ID: 31755141
[TBL] [Abstract][Full Text] [Related]
36. Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation.
Lee JW; Jang PS; Chung NG; Cho B; Kim HK
Br J Haematol; 2013 Jan; 160(1):80-6. PubMed ID: 23106148
[TBL] [Abstract][Full Text] [Related]
37. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
38. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Zhang H; Zhang N; Wang R; Shao T; Feng Y; Yao Y; Wu Q; Zhu S; Cao J; Zhang H; Li Z; Liu X; Niu M; Xu K
J Transl Med; 2019 Apr; 17(1):106. PubMed ID: 30935386
[TBL] [Abstract][Full Text] [Related]
39. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.
Versluis J; Hazenberg CL; Passweg JR; van Putten WL; Maertens J; Biemond BJ; Theobald M; Graux C; Kuball J; Schouten HC; Pabst T; Löwenberg B; Ossenkoppele G; Vellenga E; Cornelissen JJ;
Lancet Haematol; 2015 Oct; 2(10):e427-36. PubMed ID: 26686044
[TBL] [Abstract][Full Text] [Related]
40. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
